Recent work has begun to redefine how SCLC is classified, highlighting at least four molecular subtypes, one of which was proposed to express YAP [107], although the use of YAP as a biomarker for this subtype is controversial [112,114,116,117]. Here, YAP1 is linked to small cell lung carcinoma.